Management of Urological Malignancy in Heart and Lung Transplant Recipients: An Irish National Cohort Study

CONCLUSIONS: Urological malignancies are not common in heart and lung transplant recipients; however, standard management options can be safely used, including radical surgery. Prospective monitoring of these patients and potential considerations for screening should be maintained.PMID:34641776 | DOI:10.6002/ect.2021.0206

Source: Clinical Prostate Cancer - October 13, 2021 Category: Cancer & Oncology Authors: Robert A Keenan Usman Haroon Paul Ryan Bronagh Harrington Andrew Jones Mohammed Aboelmagd Stephen Connolly Kiaran J O'Mally David Galvin Nicholas Hegarty Source Type: research